Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) is an emerging specialty pharmaceutical company focused on the clinical and commercial development of new products that meet the needs of acute care practitioners and their patients.
A Focus on Pain Management
Our primary focus lies in the development of non-opioid products for postsurgical pain control. We believe we have the technology to improve products' efficacy and safety and make a critical difference to patients in terms of dosing frequency and administration.
- EXPAREL® (bupivacaine liposome injectable suspension) is a non-opioid local analgesic indicated for administration into the surgical site to produce postsurgical analgesia. EXPAREL combines bupivacaine with the DepoFoam® drug delivery platform to provide postsurgical pain control with a single intraoperative infiltration.
See how EXPAREL is manufactured at the Pacira Science Center Campus.
- Our proven product delivery technology, DepoFoam, is a multivesicular liposome technology that encapsulates drugs without altering their molecular structure and then releases them over a desired time period (from 1 to 30 days); it has been used to reduce the dosing frequency and extend the duration of action of DepoCyt(e)® for over a decade.